1. Home
  2. MLYS vs CNOB Comparison

MLYS vs CNOB Comparison

Compare MLYS & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • CNOB
  • Stock Information
  • Founded
  • MLYS 2019
  • CNOB 1982
  • Country
  • MLYS United States
  • CNOB United States
  • Employees
  • MLYS N/A
  • CNOB N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • CNOB Major Banks
  • Sector
  • MLYS Health Care
  • CNOB Finance
  • Exchange
  • MLYS Nasdaq
  • CNOB Nasdaq
  • Market Cap
  • MLYS 1.0B
  • CNOB 1.2B
  • IPO Year
  • MLYS 2023
  • CNOB 1996
  • Fundamental
  • Price
  • MLYS $13.67
  • CNOB $22.24
  • Analyst Decision
  • MLYS Strong Buy
  • CNOB Buy
  • Analyst Count
  • MLYS 4
  • CNOB 1
  • Target Price
  • MLYS $27.00
  • CNOB $31.00
  • AVG Volume (30 Days)
  • MLYS 692.8K
  • CNOB 357.4K
  • Earning Date
  • MLYS 08-12-2025
  • CNOB 07-29-2025
  • Dividend Yield
  • MLYS N/A
  • CNOB 3.24%
  • EPS Growth
  • MLYS N/A
  • CNOB N/A
  • EPS
  • MLYS N/A
  • CNOB 0.82
  • Revenue
  • MLYS N/A
  • CNOB $241,854,000.00
  • Revenue This Year
  • MLYS N/A
  • CNOB $46.52
  • Revenue Next Year
  • MLYS N/A
  • CNOB $29.92
  • P/E Ratio
  • MLYS N/A
  • CNOB $27.28
  • Revenue Growth
  • MLYS N/A
  • CNOB N/A
  • 52 Week Low
  • MLYS $8.24
  • CNOB $20.08
  • 52 Week High
  • MLYS $18.38
  • CNOB $29.31
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 45.18
  • CNOB 32.36
  • Support Level
  • MLYS $13.41
  • CNOB $23.73
  • Resistance Level
  • MLYS $15.15
  • CNOB $24.72
  • Average True Range (ATR)
  • MLYS 0.73
  • CNOB 0.71
  • MACD
  • MLYS 0.01
  • CNOB -0.34
  • Stochastic Oscillator
  • MLYS 25.36
  • CNOB 1.47

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

About CNOB ConnectOne Bancorp Inc.

ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.

Share on Social Networks: